Clinical Trial Update: A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) [Phase 1, Phase 2]

View source ↗

Summary

SP-101 is being evaluated in a Phase 1/2 clinical trial for cystic fibrosis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• SP-101

Snippet

Sponsor: Spirovant Sciences, Inc. | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: RECRUITING